Literature DB >> 23063076

Prostanoids as regulators of innate and adaptive immunity.

Takako Hirata1, Shuh Narumiya.   

Abstract

Potent, oxygenated lipid molecules called prostanoids regulate a wide variety of physiological responses and pathological processes. Prostanoids are produced by various cell types and act on target cells through specific G protein-coupled receptors. Although prostanoids have historically been considered acute inflammation mediators, studies using specific receptor knockout mice indicate that prostanoids, in fact, regulate various aspects of both innate and adaptive immunity. Each prostanoid, depending on which receptor it acts on, exerts specific effects on immune cells such as macrophages, dendritic cells, and T and B lymphocytes, often in concert with microbial ligands and cytokines, to affect the strength, quality, and duration of immune responses. Prostanoids are also relevant to immunopathology, from inflammation to autoimmunity and cancer. Here, we review the role of prostanoids in regulating immunity, their involvement in immunopathology, and areas of insight that may lead to new therapeutic opportunities.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23063076     DOI: 10.1016/B978-0-12-394300-2.00005-3

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  41 in total

1.  B-cell development: COX-1 joins the game.

Authors:  Cosima T Baldari
Journal:  Blood       Date:  2014-09-04       Impact factor: 22.113

Review 2.  Bioactive Fatty Acids in the Resolution of Chronic Inflammation in Skin Wounds.

Authors:  Carlos Poblete Jara; Natália Ferreira Mendes; Thais Paulino do Prado; Eliana Pereira de Araújo
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-06-23       Impact factor: 4.730

3.  Endogenous PGI2 signaling through IP inhibits neutrophilic lung inflammation in LPS-induced acute lung injury mice model.

Authors:  Shinji Toki; Weisong Zhou; Kasia Goleniewska; Sara Reiss; Daniel E Dulek; Dawn C Newcomb; William E Lawson; R Stokes Peebles
Journal:  Prostaglandins Other Lipid Mediat       Date:  2018-04-13       Impact factor: 3.072

4.  Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages.

Authors:  Milena Sokolowska; Li-Yuan Chen; Yueqin Liu; Asuncion Martinez-Anton; Hai-Yan Qi; Carolea Logun; Sara Alsaaty; Yong Hwan Park; Daniel L Kastner; Jae Jin Chae; James H Shelhamer
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

Review 5.  Polyunsaturated fatty acid derived signaling in reproduction and development: insights from Caenorhabditis elegans and Drosophila melanogaster.

Authors:  Tracy L Vrablik; Jennifer L Watts
Journal:  Mol Reprod Dev       Date:  2013-03-14       Impact factor: 2.609

6.  Lysophospholipid acyltransferases and eicosanoid biosynthesis in zebrafish myeloid cells.

Authors:  Simona Zarini; Joseph A Hankin; Robert C Murphy; Miguel A Gijón
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-08-28       Impact factor: 3.072

Review 7.  Eicosanoids and Keratinocytes in Wound Healing.

Authors:  Raja K Sivamani
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-07-01       Impact factor: 4.730

Review 8.  Metabolic pathways in immune cell activation and quiescence.

Authors:  Erika L Pearce; Edward J Pearce
Journal:  Immunity       Date:  2013-04-18       Impact factor: 31.745

9.  International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions.

Authors:  Xavier Norel; Yukihiko Sugimoto; Gulsev Ozen; Heba Abdelazeem; Yasmine Amgoud; Amel Bouhadoun; Wesam Bassiouni; Marie Goepp; Salma Mani; Hasanga D Manikpurage; Amira Senbel; Dan Longrois; Akos Heinemann; Chengcan Yao; Lucie H Clapp
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

Review 10.  Lipid mediators and allergic diseases.

Authors:  Laura B Fanning; Joshua A Boyce
Journal:  Ann Allergy Asthma Immunol       Date:  2013-07-21       Impact factor: 6.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.